• The specific situation of the patient. Unless otherwise provided for by national regulations,
off-label use of medication should be limited to situations where it is in the patient's interest …

Atherosclerotic cardiovascular disease (CVD) is a chronic disorder develo** insidiously
throughout life and usually progressing to an advanced stage by the time symptoms occur. It …

Recommendations about therapy for hypertension are here preceded by some
considerations on the strength of available evidence on the benefits associated with …

The global prevalence of dementia is as high as 24 million, and has been predicted to
quadruple by the year 2050. In the US alone, Alzheimer disease (AD)–the most frequent …

Importance The benefit of blood pressure lowering for the prevention of dementia or
cognitive impairment is unclear. Objective To determine the association of blood pressure …

Alzheimer's disease (AD) is the most common type of dementia and typically manifests
through a progressive loss of episodic memory and cognitive function, subsequently causing …

2003 European Society of Hypertension–European Society of Ca... : Journal of
Hypertension 2003 European Society of Hypertension–European Society of Cardiology …

Background The mechanisms by which hypertension causes vascular events are unclear.
Guidelines for diagnosis and treatment focus only on underlying mean blood pressure. We …

The global prevalence of dementia is estimated to be as high as 24 million, and is predicted
to double every 20 years through to 2040, leading to a costly burden of disease. Alzheimer …

†European guidelines on cardiovascular disease prevention in clinical practice: executive
summary | European Heart Journal | Oxford Academic Skip to Main Content Advertisement …